JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265991

Human DGKD knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

DGKD KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 14. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.

View Alternative Names

130 kDa diacylglycerol kinase, DAG kinase delta, DGK-delta, DGKD_HUMAN, Diacylglycerol kinase delta, Diglyceride kinase delta, FLJ26930, KIAA0145

2 Images
Cell Culture - Human DGKD knockout HeLa cell line (AB265991)
  • Cell Culture

Lab

Cell Culture - Human DGKD knockout HeLa cell line (AB265991)

Representative images DGKD knockout HeLa cells, low and high confluency examples (top left and right respectively) and wild-type HeLa cells, low and high confluency (bottom left and right respectively) showing typical adherent, epithelial-like morphology. Images were captured at 10X magnification using a EVOS M5000 microscope.

Sanger Sequencing - Human DGKD knockout HeLa cell line (AB265991)
  • Sanger seq

Unknown

Sanger Sequencing - Human DGKD knockout HeLa cell line (AB265991)

Homozygous : 1 bp deletion in exon 14.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 14

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265991-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265991 Human DGKD knockout HeLa cell line", "number":"AB265991-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265991-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265991-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265991-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265991 Human DGKD knockout HeLa cell line", "number":"AB265991-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265991-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265991 Human DGKD knockout HeLa cell line", "number":"AB265991-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265991-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265991 Human DGKD knockout HeLa cell line", "number":"AB265991-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
DGKD
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

DGKD also known as Diacylglycerol kinase delta plays an essential role in lipid signaling by converting diacylglycerol (DAG) into phosphatidic acid (PA). This enzymatic activity impacts cellular processes such as growth and differentiation. The DGKD protein has a molecular mass of approximately 130 kDa and is expressed in various tissues with significant expression noted in the brain and muscle. The gene encoding DGKD is located on human chromosome 13 providing insights into its systemic importance.
Biological function summary

DGKD participates in regulating intracellular signaling. DGKD modulates signal transduction by altering levels of second messengers like DAG. This regulation occurs because DGKD acts as a part of lipid kinase activities impacting membrane-bound complexes involved in signal pathways. These activities can play roles in neurotransmitter release and cellular responses to external stimuli signifying their critical involvement in maintaining cellular homeostasis.

Pathways

DGKD plays a role in the phosphatidylinositol signaling system by interacting with and regulating proteins such as Protein Kinase C (PKC). This involvement means that it influences the kinase activity responsible for numerous cellular responses including cell growth apoptosis and metabolism. Additionally DGKD appears in the broader MAPK/ERK pathway indicating links with cellular proliferation and survival signals and suggesting its interconnectedness with a network of kinases and phosphatases.

DGKD abnormalities have connections with conditions like insulin resistance and neurological disorders. Studies point out its potential interaction with proteins like IRS1 in insulin signaling pathways where altered DGKD function might influence metabolic pathways leading to insulin resistance. Furthermore its significant presence in the brain suggests possible links to neurological conditions potentially through influencing synaptic signal regulation or cellular communication networks.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com